Ketotifeno Dermogen (Ketotifen Hydrogen Fumarate)

Ketotifen acts as an H1‑receptor antagonist, blocking histamine from binding to its receptors on ocular tissues. At the same time, it stabilizes mast cells, preventing the release of inflammatory mediators like histamine, prostaglandins, and leukotrienes, which together reduce redness, itching, and swelling.

The dosing regimen for Ketotifeno Dermogen is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the specific instructions provided by their doctor or pharmacist.

Safety data for ketotifen hydrogen fumarate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ketotifeno Dermogen combines H1‑receptor antagonism with mast‑cell stabilization, offering both immediate symptom relief and longer‑term control. Compared with antihistamines that lack mast‑cell stabilizing activity, ketotifen may provide more sustained reduction of allergic inflammation, though individual response can vary.

The product should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed in its original packaging to maintain sterility and potency until the expiration date.

Ketotifeno Dermogen is applied topically to the eye. The prescribed number of drops is placed into the lower conjunctival sac of the affected eye(s) as directed by the prescriber, typically avoiding contact with the tip of the bottle to maintain sterility.

Serious risks, though rare, include severe allergic reactions such as angio‑edema, persistent eye pain, vision loss, or corneal ulceration. Patients should seek immediate medical attention if they experience any of these symptoms.

Individuals with a known hypersensitivity to ketotifen, any component of the formulation, or those with active ocular infections should avoid using the product unless advised otherwise by a qualified eye care professional.